NCT00320931

Brief Summary

There have been many advances in the test used to look for heart disease. An example of this newer technology is the Multislice CT scan (MSCT) and Positron Emission Tomography (PET) scans. The use of this type of combined scan may show early coronary artery disease or the degree of damaged heart muscle form a heart attack with a single exam. It may help doctors to know who might benefit from heart surgery or angioplasty to increase the blood flow to the heart. This type of detailed images has previously been available only through cardiac catheterization.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable coronary-artery-disease

Timeline
Completed

Started Mar 2006

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2006

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 28, 2006

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 3, 2006

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2008

Completed
13.2 years until next milestone

Results Posted

Study results publicly available

June 9, 2021

Completed
Last Updated

June 9, 2021

Status Verified

May 1, 2021

Enrollment Period

2.1 years

First QC Date

April 28, 2006

Results QC Date

August 20, 2010

Last Update Submit

May 17, 2021

Conditions

Keywords

Coronary artery diseasePET CT scanStress testRubidium

Outcome Measures

Primary Outcomes (1)

  • The Incremental Value of Adenosine Flow Reserve by Rubidium PET to Clinically Acquired Gated Studies.

    All data were acquired in list-mode for 8 minutes and retrospectively sorted into static, ECG gated and dynamic images. Rubidium retention was calculated by dividing the late (3-8 minute) whole myocardium region-of-interest data by the integral of the input function over the first minute. Adenosine flow reserve was estimated by dividing rubidium retention during adenosine vasodilation by the same measure at rest. These quantitative flow and flow reserve values were compared to clinically acquired gated studies in the 30 participants.

    3-8 minute

Study Arms (1)

Hybrid PET/CT

EXPERIMENTAL
Device: Hybrid PET/CT

Interventions

Rest and vasodilation stress rubidium PET and coronary angiography with CT were performed using standard doses for clinically indicated studies.

Also known as: Philips Gemini
Hybrid PET/CT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject must be 18 years of age or older and able to give informed consent.
  • Scheduled for clinically indicated gated Adenoscan SPECT studies at the University of Maryland Medical Center or Baltimore VA Center
  • Documentation from participant's health care provider indicating no objection to subject's participation in study.

You may not qualify if:

  • Hepatic; thyroid or renal disease (creatinine \>1.5 or GFR \< 60mL/min)
  • Women of childbearing age not using medically acceptable form of contraception, pregnant or breast-feeding
  • Contrast allergy
  • Inability to cooperate with imaging

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Maryland Medical Center

Baltimore, Maryland, 21201, United States

Location

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Limitations and Caveats

For rubidium PET, statistical noise in static or gated images and quantitative accuracy in early-phase dynamic images could not be simultaneously optimized on the hybrid PET/CT scanner.

Results Point of Contact

Title
Vasken Dilsizian, MD
Organization
University of Maryland, Baltimore

Study Officials

  • Vasken Dilsizian, M.D.

    University of Maryland, College Park

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 28, 2006

First Posted

May 3, 2006

Study Start

March 1, 2006

Primary Completion

April 1, 2008

Study Completion

April 1, 2008

Last Updated

June 9, 2021

Results First Posted

June 9, 2021

Record last verified: 2021-05

Locations